Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

300 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Differentiation of cardiomyocytes and generation of human engineered heart tissue.
Breckwoldt K, Letuffe-Brenière D, Mannhardt I, Schulze T, Ulmer B, Werner T, Benzin A, Klampe B, Reinsch MC, Laufer S, Shibamiya A, Prondzynski M, Mearini G, Schade D, Fuchs S, Neuber C, Krämer E, Saleem U, Schulze ML, Rodriguez ML, Eschenhagen T, Hansen A. Breckwoldt K, et al. Among authors: rodriguez ml. Nat Protoc. 2017 Jun;12(6):1177-1197. doi: 10.1038/nprot.2017.033. Epub 2017 May 11. Nat Protoc. 2017. PMID: 28492526
Author Correction: Differentiation of cardiomyocytes and generation of human engineered heart tissue.
Breckwoldt K, Brenière-Letuffe D, Mannhardt I, Schulze T, Ulmer B, Werner T, Benzin A, Klampe B, Reinsch MC, Laufer S, Shibamiya A, Prondzynski M, Mearini G, Schade D, Fuchs S, Neuber C, Krämer E, Saleem U, Schulze ML, Rodriguez ML, Eschenhagen T, Hansen A. Breckwoldt K, et al. Among authors: rodriguez ml. Nat Protoc. 2019 Sep;14(9):2748. doi: 10.1038/s41596-019-0228-5. Nat Protoc. 2019. PMID: 31384055
Differential susceptibility and role for senescence in CART cells based on costimulatory domains.
Can I, Siegler EL, Sirpilla OL, Manriquez-Roman C, Yun K, Stewart CM, Feigin JM, Rodriguez ML, Gutierrez-Ruiz OL, Ogbodo EJ, Huynh TN, Kimball BL, Mai LK, Hefazi M, Fonkoua LK, Xia H, Hamaidi I, Alkan B, Sezer F, Ekiz HA, Sakemura RL, Kenderian SS. Can I, et al. Among authors: rodriguez ml. Mol Cancer. 2025 Jun 10;24(1):172. doi: 10.1186/s12943-025-02371-1. Mol Cancer. 2025. PMID: 40495168 Free PMC article.
Adaptive multi-epitope targeting and avidity-enhanced nanobody platform for ultrapotent, durable antiviral therapy.
Xiang Y, Xu J, McGovern BL, Ranzenigo A, Huang W, Sang Z, Shen J, Diaz-Tapia R, Pham ND, Teunissen AJP, Rodriguez ML, Benjamin J, Taylor DJ, van Leent MMT, White KM, García-Sastre A, Zhang P, Shi Y. Xiang Y, et al. Among authors: rodriguez ml. Cell. 2024 Nov 27;187(24):6966-6980.e23. doi: 10.1016/j.cell.2024.09.043. Epub 2024 Oct 23. Cell. 2024. PMID: 39447570 Free PMC article.
Nirmatrelvir and molnupiravir maintain potent in vitro and in vivo antiviral activity against circulating SARS-CoV-2 omicron subvariants.
Rosales R, McGovern BL, Rodriguez ML, Leiva-Rebollo R, Diaz-Tapia R, Benjamin J, Rai DK, Cardin RD, Anderson AS; PSP study group; Sordillo EM, van Bakel H, Simon V, García-Sastre A, White KM. Rosales R, et al. Among authors: rodriguez ml. Antiviral Res. 2024 Oct;230:105970. doi: 10.1016/j.antiviral.2024.105970. Epub 2024 Jul 25. Antiviral Res. 2024. PMID: 39067667
300 results